Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study. / Jensen, Kristoffer Jarlov; Gronemann, Frederikke Hørdam; Ankarfeldt, Mikkel Zöllner; Jimenez-Solem, Espen; Alulis, Sarah; Riise, Jesper; Bødker, Nikolaj; Osler, Merete; Petersen, Janne.

I: PLoS ONE, Bind 17, Nr. 9, e0275299, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, KJ, Gronemann, FH, Ankarfeldt, MZ, Jimenez-Solem, E, Alulis, S, Riise, J, Bødker, N, Osler, M & Petersen, J 2022, 'Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study', PLoS ONE, bind 17, nr. 9, e0275299. https://doi.org/10.1371/journal.pone.0275299

APA

Jensen, K. J., Gronemann, F. H., Ankarfeldt, M. Z., Jimenez-Solem, E., Alulis, S., Riise, J., Bødker, N., Osler, M., & Petersen, J. (2022). Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study. PLoS ONE, 17(9), [e0275299]. https://doi.org/10.1371/journal.pone.0275299

Vancouver

Jensen KJ, Gronemann FH, Ankarfeldt MZ, Jimenez-Solem E, Alulis S, Riise J o.a. Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study. PLoS ONE. 2022;17(9). e0275299. https://doi.org/10.1371/journal.pone.0275299

Author

Jensen, Kristoffer Jarlov ; Gronemann, Frederikke Hørdam ; Ankarfeldt, Mikkel Zöllner ; Jimenez-Solem, Espen ; Alulis, Sarah ; Riise, Jesper ; Bødker, Nikolaj ; Osler, Merete ; Petersen, Janne. / Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study. I: PLoS ONE. 2022 ; Bind 17, Nr. 9.

Bibtex

@article{5c5896813f434356a811e6d95396a6f4,
title = "Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study",
abstract = "Objectives To investigate healthcare resource utilization (HRU) and associated costs by depression severity and year of diagnosis among patients with treatment-resistant depression (TRD) in Denmark. Methods Including all adult patients with a first-time hospital contact for major depressive disorder (MDD) in 1996–2015, TRD patients were defined at the second shift in depression treatment (antidepressant medicine or electroconvulsive therapy) and matched 1:2 with non-TRD patients. The risk of utilization and amount of HRU and associated costs including medicine expenses 12 months after the TRD-defining date were reported, comparing TRD patients with non-TRD MDD patients. Results Identifying 25,321 TRD-patients matched with 50,638 non-TRD patients, the risk of psychiatric hospitalization following TRD diagnosis was 138.4% (95%-confidence interval: 128.3–149.0) higher for TRD patients than for non-TRD MDD patients. The number of hospital bed days and emergency department (ED) visits were also higher among TRD patients, with no significant difference for somatic HRU. Among patients who incurred healthcare costs, the associated HRU costs for TRD patients were 101.9% (97.5–106.4) higher overall, and 55.2% (50.9–59.6) higher for psychiatric services than those of non-TRD patients. The relative differences in costs for TRD-patients vs non-TRD patients were greater for patients with mild depression and tended to increase over the study period (1996–2015), particularly for acute hospitalizations and ED visits. Limitations TRD was defined by prescription patterns besides ECT treatments. Conclusion TRD was associated with increased psychiatric-related HRU. Particularly the difference in acute hospitalizations and ED visits between TRD and non-TRD patients increased over the study period.",
author = "Jensen, {Kristoffer Jarlov} and Gronemann, {Frederikke H{\o}rdam} and Ankarfeldt, {Mikkel Z{\"o}llner} and Espen Jimenez-Solem and Sarah Alulis and Jesper Riise and Nikolaj B{\o}dker and Merete Osler and Janne Petersen",
note = "Publisher Copyright: Copyright: {\textcopyright} 2022 Jensen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",
year = "2022",
doi = "10.1371/journal.pone.0275299",
language = "English",
volume = "17",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

RIS

TY - JOUR

T1 - Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study

AU - Jensen, Kristoffer Jarlov

AU - Gronemann, Frederikke Hørdam

AU - Ankarfeldt, Mikkel Zöllner

AU - Jimenez-Solem, Espen

AU - Alulis, Sarah

AU - Riise, Jesper

AU - Bødker, Nikolaj

AU - Osler, Merete

AU - Petersen, Janne

N1 - Publisher Copyright: Copyright: © 2022 Jensen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2022

Y1 - 2022

N2 - Objectives To investigate healthcare resource utilization (HRU) and associated costs by depression severity and year of diagnosis among patients with treatment-resistant depression (TRD) in Denmark. Methods Including all adult patients with a first-time hospital contact for major depressive disorder (MDD) in 1996–2015, TRD patients were defined at the second shift in depression treatment (antidepressant medicine or electroconvulsive therapy) and matched 1:2 with non-TRD patients. The risk of utilization and amount of HRU and associated costs including medicine expenses 12 months after the TRD-defining date were reported, comparing TRD patients with non-TRD MDD patients. Results Identifying 25,321 TRD-patients matched with 50,638 non-TRD patients, the risk of psychiatric hospitalization following TRD diagnosis was 138.4% (95%-confidence interval: 128.3–149.0) higher for TRD patients than for non-TRD MDD patients. The number of hospital bed days and emergency department (ED) visits were also higher among TRD patients, with no significant difference for somatic HRU. Among patients who incurred healthcare costs, the associated HRU costs for TRD patients were 101.9% (97.5–106.4) higher overall, and 55.2% (50.9–59.6) higher for psychiatric services than those of non-TRD patients. The relative differences in costs for TRD-patients vs non-TRD patients were greater for patients with mild depression and tended to increase over the study period (1996–2015), particularly for acute hospitalizations and ED visits. Limitations TRD was defined by prescription patterns besides ECT treatments. Conclusion TRD was associated with increased psychiatric-related HRU. Particularly the difference in acute hospitalizations and ED visits between TRD and non-TRD patients increased over the study period.

AB - Objectives To investigate healthcare resource utilization (HRU) and associated costs by depression severity and year of diagnosis among patients with treatment-resistant depression (TRD) in Denmark. Methods Including all adult patients with a first-time hospital contact for major depressive disorder (MDD) in 1996–2015, TRD patients were defined at the second shift in depression treatment (antidepressant medicine or electroconvulsive therapy) and matched 1:2 with non-TRD patients. The risk of utilization and amount of HRU and associated costs including medicine expenses 12 months after the TRD-defining date were reported, comparing TRD patients with non-TRD MDD patients. Results Identifying 25,321 TRD-patients matched with 50,638 non-TRD patients, the risk of psychiatric hospitalization following TRD diagnosis was 138.4% (95%-confidence interval: 128.3–149.0) higher for TRD patients than for non-TRD MDD patients. The number of hospital bed days and emergency department (ED) visits were also higher among TRD patients, with no significant difference for somatic HRU. Among patients who incurred healthcare costs, the associated HRU costs for TRD patients were 101.9% (97.5–106.4) higher overall, and 55.2% (50.9–59.6) higher for psychiatric services than those of non-TRD patients. The relative differences in costs for TRD-patients vs non-TRD patients were greater for patients with mild depression and tended to increase over the study period (1996–2015), particularly for acute hospitalizations and ED visits. Limitations TRD was defined by prescription patterns besides ECT treatments. Conclusion TRD was associated with increased psychiatric-related HRU. Particularly the difference in acute hospitalizations and ED visits between TRD and non-TRD patients increased over the study period.

U2 - 10.1371/journal.pone.0275299

DO - 10.1371/journal.pone.0275299

M3 - Journal article

C2 - 36166443

AN - SCOPUS:85139199078

VL - 17

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 9

M1 - e0275299

ER -

ID: 327135432